1. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody. Issue 8 (August 2018) Authors: Liew, A.; Baustian, C.; Thomas, D.; Vaughan, E.; Sanz-Nogués, C.; Creane, M.; Chen, X.; Alagesan, S.; Owens, P.; Horan, J.; Dockery, P.; Griffin, M. D.; Duffy, A.; O'Brien, T. Journal: Cell transplantation Issue: Volume 27:Issue 8(2018) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗